Stoke Therapeutics Inc (STOK)
$12.91 -$0.35 (-2.64%) 12:15 PM 12/11/24
NASDAQ | $USD | BiotechnologyStock Data
-
Market Cap
$702.87M -
Day's Range
$12.76 - $13.37 -
Volume
667,992 -
52 Week Low / High
$4.09 - $17.58 -
PE Ratio
- -
PEG Ratio
- -
Dividend Frequency
-
STOK's Dividend
Hypothetical 10k Investment Jan 1, 2020
- Capital Growth
- Dividend Return to Date
- Dividend Payout year Est.
- Expenses
- Total Return
- Total Return %
Analyists Ranking
- 6
- Strong Buy
- 2
- Buy
- 1
- Hold
- 0
- Sell
- 0
- Strong Sell
- $22.00
- Target Price
Company News
-
Stoke Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) — Jan 17th, 2024
BEDFORD, Mass., January 17, 2024--(BUSINESS WIRE)--Stoke Therapeutics, Inc. (Nasdaq: STOK), a biotechnology company dedicated to addressing the underlying cause of severe diseases by upregulating protein expression with RNA-based medicines, today announced that, effective on January 16, 20...
Similar Stocks
No similar stocks found.
|
Portfolio
$5,000/year
Goal: $10,000/year
Comprised of 1 portfolios
$